印度一家三级保健医院癌症化疗药物浪费情况：一项为期 3 个月的前瞻性和 1 年回顾性研究。
Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective study.
机构信息
Department of Pharmacology, NEIGRIHMS, India.
Department of Radiation Oncology, NEIGRIHMS, India.
出版信息
Br J Clin Pharmacol. 2019 Oct;85(10):2428-2435. doi: 10.1111/bcp.14064. Epub 2019 Aug 1.
Abstract
This study prospectively quantified wastage of cancer chemotherapeutic drugs in an oncology unit to find the associated cost in 3 months. Retrospective analysis of drug usage for 12 months was also conducted to determine the expected drug loss in 1 year. The effect of vial sharing was evaluated under the assumption of sharing. A significant drug wastage of 19.72% (95% confidence interval [CI], 14.52-24.93%) in 3 months and 17.14% (95% CI 14.69-19.59%) in 1 year occurred in our oncology unit. Number of vials purchased (r = 0.362, p < 0.01), weight (r = -0.146, P < .01) and body surface area (r = -0.26, P < .01) correlated with the drug wasted. Vial sharing assumption showed a 9% (95% CI, 2.5-15.5%) reduction in cost in 1 year.
摘要
本研究前瞻性地量化了肿瘤科中癌症化疗药物的浪费情况，以在 3 个月内发现相关成本。还对 12 个月的药物使用情况进行了回顾性分析，以确定 1 年内预计的药物损失。在假设共享的情况下，评估了小瓶共享的效果。我们肿瘤科在 3 个月和 1 年内分别发生了 19.72%（95%置信区间 [CI]，14.52-24.93%）和 17.14%（95% CI 14.69-19.59%）的显著药物浪费。购买的小瓶数量（r=0.362，p<0.01）、重量（r=-0.146，P<.01）和体表面积（r=-0.26，P<.01）与浪费的药物相关。小瓶共享假设表明，1 年内成本降低了 9%（95%CI，2.5-15.5%）。
相似文献
1
Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective study.印度一家三级保健医院癌症化疗药物浪费情况：一项为期 3 个月的前瞻性和 1 年回顾性研究。
Br J Clin Pharmacol. 2019 Oct;85(10):2428-2435. doi: 10.1111/bcp.14064. Epub 2019 Aug 1.
2
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States.美国非小细胞肺癌患者护理中的药物浪费及医疗系统成本
J Med Econ. 2018 Aug;21(8):755-761. doi: 10.1080/13696998.2018.1467918. Epub 2018 May 11.
3
The impact of cancer drug wastage on economic evaluations.癌症药物浪费对经济评估的影响。
Cancer. 2017 Sep 15;123(18):3583-3590. doi: 10.1002/cncr.30807. Epub 2017 Jun 22.
4
Financial audit of wastage of anticancer drugs: Pilot study from a tertiary care center in India.抗癌药物浪费情况的财务审计：来自印度一家三级医疗中心的初步研究。
Indian J Cancer. 2019 Apr-Jun;56(2):146-150. doi: 10.4103/ijc.IJC_169_18.
5
Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India.儿童癌症护理中化疗药物浪费及造成的经济损失量化：印度一家三级护理公立医院的横断面研究
Cureus. 2024 Jan 11;16(1):e52076. doi: 10.7759/cureus.52076. eCollection 2024 Jan.
6
Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation.摩洛哥一家医院化疗制剂集中调配单元的集中化影响及成本节约研究
J Oncol Pharm Pract. 2020 Oct;26(7):1630-1636. doi: 10.1177/1078155220901336. Epub 2020 Feb 11.
7
Quantifying Drug Wastage and Economic Loss of Chemotherapy Drugs at an Adult Oncology Care of a Tertiary Care Public Hospital in India.印度一家三级护理公立医院成人肿瘤护理中化疗药物的药物浪费及经济损失量化
Cureus. 2023 Nov 22;15(11):e49242. doi: 10.7759/cureus.49242. eCollection 2023 Nov.
8
A real-world analysis of cancer drug wastage due to oversized vials.超大规格药瓶导致癌症药物浪费的真实世界分析。
J Am Pharm Assoc (2003). 2018 Nov-Dec;58(6):643-646. doi: 10.1016/j.japh.2018.06.004. Epub 2018 Jul 13.
9
Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation Strategies.癌症药物浪费的财务影响以及缓解策略可能带来的成本节约。
J Oncol Pract. 2017 Jul;13(7):e646-e652. doi: 10.1200/JOP.2017.022905. Epub 2017 Jun 12.
10
Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.评估肠外化疗药物剂量取整对成本节约和药物浪费最小化的潜在影响。
J Oncol Pharm Pract. 2018 Oct;24(7):507-510. doi: 10.1177/1078155217722205. Epub 2017 Jul 21.
引用本文的文献
1
A real-word survey of anticancer drug wastage in a public chemotherapy center in the west of Iran.伊朗西部一家公共化疗中心抗癌药物浪费情况的真实世界调查。
Caspian J Intern Med. 2025 Mar 21;16(2):314-319. doi: 10.22088/cjim.16.2.314. eCollection 2025 Spring.
2
Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India.儿童癌症护理中化疗药物浪费及造成的经济损失量化：印度一家三级护理公立医院的横断面研究
Cureus. 2024 Jan 11;16(1):e52076. doi: 10.7759/cureus.52076. eCollection 2024 Jan.
3
Combining the Real-Time Vial Sharing Strategy with Daily-Rate Charge Mode for Antimicrobial Drugs of Inpatients: An Economical and Practical Method for Patients and Hospitals.将实时药瓶共享策略与住院患者抗菌药物日剂量收费模式相结合：一种对患者和医院都经济实用的方法。
Risk Manag Healthc Policy. 2023 Aug 14;16:1521-1530. doi: 10.2147/RMHP.S418886. eCollection 2023.
4
Cost analysis of implementing a vial-sharing strategy for chemotherapy drugs using intelligent dispensing robots in a tertiary Chinese hospital in Sichuan.在中国四川的一家三级医院中使用智能配药机器人实施化疗药物小瓶共享策略的成本分析。
Front Public Health. 2022 Sep 21;10:936686. doi: 10.3389/fpubh.2022.936686. eCollection 2022.
5
Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital.基于癌症医院的数据估计优化抗癌药物小瓶对日本医疗费用的影响。
BMC Health Serv Res. 2020 Nov 9;20(1):1017. doi: 10.1186/s12913-020-05822-1.
本文引用的文献
1
A real-world analysis of cancer drug wastage due to oversized vials.超大规格药瓶导致癌症药物浪费的真实世界分析。
J Am Pharm Assoc (2003). 2018 Nov-Dec;58(6):643-646. doi: 10.1016/j.japh.2018.06.004. Epub 2018 Jul 13.
2
Dosing Patterns and Economic Burden of Palbociclib Drug Wastage in HR+/HER2- Metastatic Breast Cancer.帕博西尼药物浪费的剂量模式和经济负担在 HR+/HER2-转移性乳腺癌。
Adv Ther. 2018 Jun;35(6):768-778. doi: 10.1007/s12325-018-0701-5. Epub 2018 Jun 4.
3
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States.美国非小细胞肺癌患者护理中的药物浪费及医疗系统成本
J Med Econ. 2018 Aug;21(8):755-761. doi: 10.1080/13696998.2018.1467918. Epub 2018 May 11.
4
Financial impact of oral chemotherapy wastage on society and the patient.口服化疗药物浪费对社会和患者的经济影响。
J Oncol Pharm Pract. 2019 Jun;25(4):824-830. doi: 10.1177/1078155218762596. Epub 2018 Mar 25.
5
Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology/Oncology Pharmacy Association.生物制剂和细胞毒性抗癌药物的剂量调整：血液学/肿瘤学药学协会的立场声明。
J Oncol Pract. 2018 Mar;14(3):e130-e136. doi: 10.1200/JOP.2017.025411. Epub 2018 Feb 5.
6
A global comparison of the cost of patented cancer drugs in relation to global differences in wealth.专利抗癌药物成本与全球财富差异的全球比较。
Oncotarget. 2017 May 9;8(42):71548-71555. doi: 10.18632/oncotarget.17742. eCollection 2017 Sep 22.
7
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer.帕博利珠单抗一线治疗 PD-L1 阳性非小细胞肺癌的个体化剂量与固定剂量的药物经济学分析。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx063.
8
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib.优化接受伊马替尼、舒尼替尼和帕唑帕尼治疗的癌症患者的剂量。
Br J Clin Pharmacol. 2017 Oct;83(10):2195-2204. doi: 10.1111/bcp.13327. Epub 2017 Jul 4.
9
Overspending driven by oversized single dose vials of cancer drugs.超大剂量单剂量瓶癌症药物导致的超支。
BMJ. 2016 Feb 29;352:i788. doi: 10.1136/bmj.i788.
10
Adjusting for Drug Wastage in Economic Evaluations of New Therapies for Hematologic Malignancies: A Systematic Review.血液系统恶性肿瘤新疗法经济评估中药物浪费的调整：一项系统评价
J Oncol Pract. 2016 Apr;12(4):e369-79. doi: 10.1200/JOP.2015.005876. Epub 2015 Sep 1.
Zotero 插件